Interleukin-23 Antagonist [EPC] - N0000192799

  1. Home
  2. Pharmacologic Class Index
  3. Interleukin-23 Antagonist [EPC] - N0000192799

Pharmacologic Class Information

Pharmacologic Code N0000192799
Pharmacologic Name Interleukin-23 Antagonist
Pharmacologic Uses
  • interleukin-12 antagonist
  • interleukin-23 antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Interleukin-23 Antagonist

The table contains 8 products whose active ingredient are classified under the same pharmacologic class Interleukin-23 Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0074-1050Skyrizi Non-Proprietary Name: Risankizumab-rzaaInjectionSubcutaneousAbbvie Inc.ACTIVE
0074-2100Skyrizi Non-Proprietary Name: Risankizumab-rzaaInjectionSubcutaneousAbbvie Inc.ACTIVE
0074-5015Skyrizi Non-Proprietary Name: Risankizumab-rzaaInjectionIntravenousAbbvie Inc.ACTIVE
47335-177Ilumya Non-Proprietary Name: Tildrakizumab-asmnInjection, SolutionSubcutaneousSun Pharmaceutical Industries, Inc.ACTIVE
57894-054Stelara Non-Proprietary Name: UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-060Stelara Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-061Stelara Non-Proprietary Name: UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-640Tremfya Non-Proprietary Name: GuselkumabInjectionSubcutaneousJanssen Biotech, Inc.ACTIVE